摘要:对抗mapk靶向治疗的获得性耐药赋予了免疫逃避肿瘤微环境和对免疫治疗的交叉耐药

{"title":"摘要:对抗mapk靶向治疗的获得性耐药赋予了免疫逃避肿瘤微环境和对免疫治疗的交叉耐药","authors":"A. Obenauf","doi":"10.1158/2326-6074.tumimm21-ia20","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":232585,"journal":{"name":"Combinatorial Studies to Overcome Resistance to Immunotherapy","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract IA20: What does not kill it makes it stronger: Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy\",\"authors\":\"A. Obenauf\",\"doi\":\"10.1158/2326-6074.tumimm21-ia20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":232585,\"journal\":{\"name\":\"Combinatorial Studies to Overcome Resistance to Immunotherapy\",\"volume\":\"25 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Combinatorial Studies to Overcome Resistance to Immunotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/2326-6074.tumimm21-ia20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Combinatorial Studies to Overcome Resistance to Immunotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/2326-6074.tumimm21-ia20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}